Skip to content
10-Q

Quarterly Report

Acorda Therapeutics, Inc.

0000950170-23-039975

← back to feed
Filed
Aug 9, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Aug 4, 2023 1.24M sh
Shares Diluted Q2 2023 · Jun 30, 2023 1.24M sh
Shares Diluted Q2 2023 · Jun 30, 2023 1.24M sh
Shares Diluted restated Q2 2023 · Jun 30, 2022 864K sh
Shares Diluted restated Q2 2023 · Jun 30, 2022 732K sh
Operating Cash Flow Q2 2023 · Jun 30, 2023 −$18.57M
Operating Cash Flow Q2 2023 · Jun 30, 2022 −$28.15M
Cash And Equivalents Q2 2023 · Jun 30, 2023 $25.27M
Cash And Equivalents Q2 2023 · Dec 31, 2022 $37.54M
Cash And Equivalents Q2 2023 · Jun 30, 2022 $23.13M
Cash And Equivalents Q2 2023 · Dec 31, 2021 $45.63M
Stockholders Equity Q2 2023 · Jun 30, 2023 $67.87M
Stockholders Equity Q2 2023 · Dec 31, 2022 $93.62M
Current Liabilities Q2 2023 · Jun 30, 2023 $30.39M
Current Liabilities Q2 2023 · Dec 31, 2022 $37.95M
Current Assets Q2 2023 · Jun 30, 2023 $64.91M
Current Assets Q2 2023 · Dec 31, 2022 $82.12M
Total Assets Q2 2023 · Jun 30, 2023 $364.7M
Total Assets Q2 2023 · Dec 31, 2022 $395.6M
Eps Diluted Q2 2023 · Jun 30, 2023 −$7.55
Eps Diluted Q2 2023 · Jun 30, 2023 −$21.10
Eps Diluted restated Q2 2023 · Jun 30, 2022 −$54.01
Eps Diluted restated Q2 2023 · Jun 30, 2022 −$97.33
Eps Basic Q2 2023 · Jun 30, 2023 −$7.55
Eps Basic Q2 2023 · Jun 30, 2023 −$21.10
Eps Basic restated Q2 2023 · Jun 30, 2022 −$54.01
Eps Basic restated Q2 2023 · Jun 30, 2022 −$97.33
Sga Expense Q2 2023 · Jun 30, 2023 $21.83M
Sga Expense Q2 2023 · Jun 30, 2023 $44.34M
Sga Expense Q2 2023 · Jun 30, 2022 $30.07M
Sga Expense Q2 2023 · Jun 30, 2022 $57.01M
Rd Expense Q2 2023 · Jun 30, 2023 $1.55M
Rd Expense Q2 2023 · Jun 30, 2023 $2.94M
Rd Expense Q2 2023 · Jun 30, 2022 $1.53M
Rd Expense Q2 2023 · Jun 30, 2022 $3.22M
Net Income Q2 2023 · Jun 30, 2023 −$9.38M
Net Income Q2 2023 · Jun 30, 2023 −$26.21M
Net Income Q2 2023 · Mar 31, 2023 −$16.82M
Net Income Q2 2023 · Jun 30, 2022 −$46.68M
Net Income Q2 2023 · Jun 30, 2022 −$71.21M
Net Income Q2 2023 · Mar 31, 2022 −$24.52M
Operating Income Q2 2023 · Jun 30, 2023 −$3.63M
Operating Income Q2 2023 · Jun 30, 2023 −$15.11M
Operating Income Q2 2023 · Jun 30, 2022 −$13.92M
Operating Income Q2 2023 · Jun 30, 2022 −$30.62M
Cost Of Revenue Q2 2023 · Jun 30, 2023 $3.07M
Cost Of Revenue Q2 2023 · Jun 30, 2023 $6.3M
Cost Of Revenue Q2 2023 · Jun 30, 2022 $8.8M
Cost Of Revenue Q2 2023 · Jun 30, 2022 $14.77M
Revenue Q2 2023 · Jun 30, 2023 $29.68M
Revenue Q2 2023 · Jun 30, 2023 $51.93M
Revenue Q2 2023 · Jun 30, 2022 $31.05M
Revenue Q2 2023 · Jun 30, 2022 $53.59M
Capex Q2 2023 · Jun 30, 2022 $109K